245 related articles for article (PubMed ID: 9326364)
1. Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.
Miyagoe Y; Hanaoka K; Nonaka I; Hayasaka M; Nabeshima Y; Arahata K; Nabeshima Y; Takeda S
FEBS Lett; 1997 Sep; 415(1):33-9. PubMed ID: 9326364
[TBL] [Abstract][Full Text] [Related]
2. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
Kuang W; Xu H; Vachon PH; Liu L; Loechel F; Wewer UM; Engvall E
J Clin Invest; 1998 Aug; 102(4):844-52. PubMed ID: 9710454
[TBL] [Abstract][Full Text] [Related]
3. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
4. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD.
Moreira Soares Oliveira B; Durbeej M; Holmberg J
PLoS One; 2017; 12(8):e0181950. PubMed ID: 28771630
[TBL] [Abstract][Full Text] [Related]
5. Merosin and congenital muscular dystrophy.
Miyagoe-Suzuki Y; Nakagawa M; Takeda S
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965
[TBL] [Abstract][Full Text] [Related]
6. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
[TBL] [Abstract][Full Text] [Related]
7. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
[TBL] [Abstract][Full Text] [Related]
8. Activation of caspase-3 apoptotic pathways in skeletal muscle fibers in laminin alpha2-deficient mice.
Mukasa T; Momoi T; Momoi MY
Biochem Biophys Res Commun; 1999 Jun; 260(1):139-42. PubMed ID: 10381357
[TBL] [Abstract][Full Text] [Related]
9. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
Gawlik KI; Holmberg J; Durbeej M
Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
[TBL] [Abstract][Full Text] [Related]
10. A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish.
Gupta VA; Kawahara G; Myers JA; Chen AT; Hall TE; Manzini MC; Currie PD; Zhou Y; Zon LI; Kunkel LM; Beggs AH
PLoS One; 2012; 7(8):e43794. PubMed ID: 22952766
[TBL] [Abstract][Full Text] [Related]
11. Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.
Girgenrath M; Beermann ML; Vishnudas VK; Homma S; Miller JB
Ann Neurol; 2009 Jan; 65(1):47-56. PubMed ID: 19086074
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the lama2 gene in embryonic stem cells: laminin alpha 2 is necessary for sustenance of mature muscle cells.
Kuang W; Xu H; Vachon PH; Engvall E
Exp Cell Res; 1998 May; 241(1):117-25. PubMed ID: 9633519
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
Carmignac V; Quéré R; Durbeej M
Hum Mol Genet; 2011 Feb; 20(3):541-52. PubMed ID: 21084425
[TBL] [Abstract][Full Text] [Related]
14. Early skeletal muscle pathology and disease progress in the dy
Gawlik KI; Körner Z; Oliveira BM; Durbeej M
Sci Rep; 2019 Oct; 9(1):14324. PubMed ID: 31586140
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin alpha2 chain gene.
Besse S; Allamand V; Vilquin JT; Li Z; Poirier C; Vignier N; Hori H; Guénet JL; Guicheney P
Neuromuscul Disord; 2003 Mar; 13(3):216-22. PubMed ID: 12609503
[TBL] [Abstract][Full Text] [Related]
16. Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency.
Kuang W; Xu H; Vilquin JT; Engvall E
Lab Invest; 1999 Dec; 79(12):1601-13. PubMed ID: 10616210
[TBL] [Abstract][Full Text] [Related]
17. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
Vachon PH; Xu H; Liu L; Loechel F; Hayashi Y; Arahata K; Reed JC; Wewer UM; Engvall E
J Clin Invest; 1997 Oct; 100(7):1870-81. PubMed ID: 9312189
[TBL] [Abstract][Full Text] [Related]
18. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
Nguyen Q; Lim KRQ; Yokota T
Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
[TBL] [Abstract][Full Text] [Related]
19. Laminin α1 reduces muscular dystrophy in dy
Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
[TBL] [Abstract][Full Text] [Related]
20. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy.
Hayashi YK; Tezak Z; Momoi T; Nonaka I; Garcia CA; Hoffman EP; Arahata K
Neuromuscul Disord; 2001 May; 11(4):350-9. PubMed ID: 11369186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
